Literature DB >> 10365827

EASL International Consensus Conference on Hepatitis C. Paris, 26-28, February 1999, Consensus Statement. European Association for the Study of the Liver.

.   

Abstract

Mesh：

Year:  1999        PMID： 10365827

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  108 in total

1.  Treatment of hepatitis C infection. Review underplayed important public health issues.

Authors:  K Agarwal; D D Jones
Journal:  BMJ       Date:  1999-08-14

2.  Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month.

Authors:  A Magalini; M Puoti; V Putzolu; E Quiros-Roldan; M A Forleo; S Rossi; S Zaltron; A Spinetti; B Zanini; A Zonaro; R Solfrini; G Carosi
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 3.  Liver biopsy: when, how, by whom, and where?

Authors:  D B McGill
Journal:  Curr Gastroenterol Rep       Date:  2001-02

4.  Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment.

Authors:  F Puppo; F Torre; P Contini; M Ghio; S Brenci; R Brizzolara; N Sinelli; N Campo; F Indiveri; A Picciotto
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

5.  Combination treatment for hepatitis C is not being given.

Authors:  G R Foster; R Chapman
Journal:  BMJ       Date:  2000-10-07

Review 6.  Tolerability of treatments for viral hepatitis.

Authors:  A Gervais; N Boyer; P Marcellin
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

7.  Occurrence of false positives during testing for antibodies to hepatitis C virus among volunteer blood donors in India.

Authors:  Sukanya Raghuraman; Thenmozhi Subramaniam; Dolly Daniel; Gopalan Sridharan; Priya Abraham
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

Review 8.  Laboratory assays for diagnosis and management of hepatitis C virus infection.

Authors:  Sandra S Richter
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

9.  HCV infection should be managed in specialist centres.

Authors:  G Dusheiko
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

10.  Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.

Authors:  C Renou; P Halfon; S Pol; P Cacoub; E Jouve; J P Bronowicki; J P Arpurt; H Rifflet; M Picon; X Causse; V Canva; J Denis; A Tran; M Bourliére; D Ouzan; A Pariente; S Dantin; L Alric; V Cartier; M Reville; S Caillat-Zucman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.